Dr Max Julvé (@julvemax) 's Twitter Profile
Dr Max Julvé

@julvemax

Clinical Research Fellow in Solid Tumour Cellular Therapies @RoyalMarsdenNHS I MD(res) Immuno-oncology @ICR_London l @NIHR ACF Medical Oncology SpR @ImperialNHS

ID: 1054388082223599617

calendar_today22-10-2018 15:04:43

129 Tweet

528 Takipçi

1,1K Takip Edilen

Dr Max Julvé (@julvemax) 's Twitter Profile Photo
Dr Max Julvé
@julvemax

a year ago

Promising data from Iovance Biotherapeutics COM202 (1st line TIL+pembro in MM). Small numbers (n=23) but ORR 65% and CR in 30%. Will be important to see how data from the larger TILVANCE study compares.

Promising data from <a href="/IovanceBio/">Iovance Biotherapeutics</a> COM202 (1st line TIL+pembro in MM). Small numbers (n=23) but ORR 65% and CR in 30%. Will be important to see how data from the larger TILVANCE study compares.